Angelo Gordon & Co’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Angelo Gordon & Co’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$148K	–	61
2024 Q1	$148K	Hold	50,000	–	–	0.05%	53
2023 Q4	$151K	Hold	50,000	–	–	0.05%	59
2023 Q3	$190K	Hold	50,000	–	–	0.07%	60
2023 Q2	$219K	Hold	50,000	–	–	0.06%	70
2023 Q1	$144K	Buy	+50,000	New	+$19K	0.04%	98

Other funds holding DRTSW

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

ACM

Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

TCM

Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Angelo Gordon & Co's DRTSW Position: Q1 2023 in Review

Angelo Gordon & Co sold out of Alpha Tau Medical Warrant (DRTSW) in Q1 2023, closing a stake of 50,000 shares — an estimated $19K sold.

Angelo Gordon & Co first reported a position in DRTSW in Q1 2022 and held it in 4 quarters. The position peaked at $590K in Q1 2022. 32 funds tracked by Wall St. Rank hold DRTSW as of Q1 2023.

Angelo Gordon & Co reported no remaining Alpha Tau Medical Warrant position as of Q1 2023 after selling out during the quarter.
Angelo Gordon & Co sold 50,000 Alpha Tau Medical Warrant shares in Q1 2023, an estimated $19K.
Angelo Gordon & Co first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 4 quarters.
Angelo Gordon & Co's Alpha Tau Medical Warrant position peaked at $590K in Q1 2022.
32 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q1 2023.

Based on Angelo Gordon & Co's 13F filing for Q1 2023, filed 15 May 2023.